Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.68 |
| ▸ | LTA4H | P09960 | 2/20 | 0.64 |
| ▸ | NPC1 | O15118 | 2/20 | 0.63 |
| ▸ | RAB9A | P51151 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.63 |
| ▸ | ABL1 | P00519 | 2/20 | 0.61 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.61 |
| ▸ | BCR | P11274 | 2/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | CA7 | P43166 | 1/20 | 0.61 |
| ▸ | CA9 | Q16790 | 1/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.61 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17283658 | 1.00 | CA4 (0.68) | CA4LTA4HNPC1RAB9AKDM4E | |
| SCHEMBL9152375 | 1.00 | CA4 (0.68) | CA4LTA4HNPC1RAB9AKDM4E | |
| Biphenyl SCHEMBL11784329 | 1.00 | CA4 (0.68) | CA4LTA4HNPC1RAB9AKDM4E | |
| Bromide SCHEMBL27478794 | 0.97 | CA4 (0.65) | CA4LTA4HNPC1RAB9AKDM4E | |
| Hydrogen Sulfide SCHEMBL27551138 | 0.97 | CA4 (0.65) | CA4LTA4HNPC1RAB9AKDM4E | |
| Hydrogen Sulfide SCHEMBL27606827 | 0.97 | CA4 (0.65) | CA4LTA4HNPC1RAB9AKDM4E | |
| SCHEMBL28478235 | 0.97 | CA4 (0.65) | CA4LTA4HNPC1RAB9AKDM4E | |
| Water SCHEMBL3540832 | 0.97 | CA4 (0.65) | CA4LTA4HNPC1RAB9AKDM4E | |
| SCHEMBL29220727 | 0.97 | CA4 (0.65) | CA4LTA4HNPC1RAB9AKDM4E | |
| Water SCHEMBL1023367 | 0.97 | CA4 (0.65) | CA4LTA4HNPC1RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1471 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117623947-B | Synthesis method of bifenazate intermediate | 绍兴上虞新银邦生化有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4022391-B1 | HEAT SENSITIVE RECORDING MATERIAL WITH NON-PHENOLIC COLOR DEVELOPERS | SOLENIS TECHNOLOGIES CAYMAN LP (KY) | 2026-03-04 | — | — | EP | claimed |
| CN-119833530-A | Preparation method of hard carbon anode material derived based on esterified modified starch and application of hard carbon anode material in sodium ion battery | 南开大学 | 2025-04-15 | — | — | CN | claimed |
| CN-114667279-B | Thermosensitive recording material containing non-phenolic color developer | 索理思科技开曼公司 | 2025-03-25 | — | — | CN | claimed |
| US-12151497-B2 | Heat sensitive recording material with non-phenolic color developers | SOLENIS TECHNOLOGIES, L.P. (US) | 2024-11-26 | — | — | US | claimed |
| CN-118594607-A | Preparation method and application of heterogeneous gamma-alumina-ionic liquid-palladium catalyst | 河北工业大学 | 2024-09-06 | — | — | CN | claimed |
| CN-117623947-A | Synthesis method of bifenazate intermediate | 绍兴上虞新银邦生化有限公司 | 2024-03-01 | — | — | CN | claimed |
| US-20230167101-A1 | NOVEL INHIBITORS OF HISTONE ACETYLTRANSFERASE P300/CBP FOR CANCER THERAPY | BAYLOR COLLEGE OF MEDICINE (US) | 2023-06-01 | — | — | US | claimed |
| EP-4132508-A1 | NOVEL INHIBITORS OF HISTONE ACETYLTRANSFERASE P300/CBP FOR CANCER THERAPY | Baylor College of Medicine (US) | 2023-02-15 | — | — | EP | claimed |
| EP-4022391-A2 | HEAT SENSITIVE RECORDING MATERIAL WITH NON-PHENOLIC COLOR DEVELOPERS | Solenis Technologies Cayman, L.P. (KY) | 2022-07-06 | — | — | EP | claimed |
| US-20020173652-A1 | Process for preparing a polyaromatic compound | SHASUN PHARMA SOLUTIONS, INC. | 2002-11-21 | — | — | US | claimed |
| EP-1255715-A1 | METHOD FOR PREPARING A POLYAROMATIC COMPOUND | RHODIA CHIMIE (FR) | 2002-11-13 | — | — | EP | claimed |
| US-6388086-B1 | REACTING W 3-METHYLPYRIDINE WITH BASE; THEN EPOXY COMPOUND | KANEKA CORPORATION (JP) | 2002-05-14 | — | — | US | claimed |
| CN-1330593-A | Heat sensitive recording material | CIBA SC HOLDING AG (CH) | 2002-01-09 | — | — | CN | claimed |
| EP-1140515-A1 | HEAT SENSITIVE RECORDING MATERIAL | Ciba SC Holding AG (CH) | 2001-10-10 | — | — | EP | claimed |
| WO-2001072527-A1 | HEAT SENSITIVE RECORDING MATERIAL | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-10-04 | — | — | WO | claimed |
| WO-2001058834-A1 | METHOD FOR PREPARING A POLYAROMATIC COMPOUND | RHODIA CHIMIE (FR) | 2001-08-16 | — | — | WO | claimed |
| WO-2000035679-A1 | HEAT SENSITIVE RECORDING MATERIAL | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-06-22 | — | — | WO | claimed |
| WO-1999025707-A1 | 2-ARYLBENZO[b]THIOPHENES USEFUL FOR THE TREATMENT OF ESTROGEN DEPRIVATION SYNDROME | ELI LILLY AND COMPANY (US) | 1999-05-27 | — | — | WO | claimed |
| US-4533766-A | Process for the production of dihydroxybenzenes | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1985-08-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230167101-A1 | NOVEL INHIBITORS OF HISTONE ACETYLTRANSFERASE P300/CBP FOR CANCER THERAPY | EP300, CREBBP, HDAC1 | CA4 3640/4885LTA4H 3438/4885NPC1 3184/4885 |
| US-20020173652-A1 | Process for preparing a polyaromatic compound | PAH, ALK, ITPA | CA4 831/4885LTA4H 1311/4885NPC1 2031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.